|Description||Dementia Symptom Clinical Meaningfulness|
DGI Clinical Inc. offers an interactive disease management tool, generating individualized information about symptoms as they are experienced over time.
DGI Clinical Inc. (DGI) is a Nova Scotian company with operations in Halifax, Nova Scotia, Canada. Led by Dr. Kenneth Rockwood, a world leading dementia specialist and geriatrician, the companyâ€™s primary goal is to provide innovative health management technologies to the pharmaceutical and health care industries.
In 2006, DGI launched www.DementiaGuide.com, a web-enabled tool that responds to a market impacted by staggering costs â€“ both social and economic. With no cure in the horizon, the need for better care and treatment options is paramount to families living with dementia, health care providers and drug developers.
Designed for use by caregivers and health professionals, DementiaGuide.com is unique because, while other websites offer static information on dementia, it is interactive and it allows users to identify and manage symptoms of dementia on an individualized basis.
In addition to providing a wealth of information on Alzheimerâ€™s disease and dementia, a key feature of DementiaGuide.com is its symptom tracking tool SymptomGuideTM, where users can create symptom profiles and track symptom changes as they are experienced by a person over time. Easy-to-read reports are generated that can be shared within families, and with physicians and health care teams. In this way, SymptomGuideTM provides critical information for diagnostic, treatment and disease management decisions.
In addition, SymptomGuideTMâ€™s functionality provides for aggregation of data for analysis and customized reporting to pharmaceutical companies. DGI offers time and cost saving solutions to the pharmaceutical industry’s need to understand how their drugs work both in clinical trials and in post marketing.